HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
| Autor: | Dugel, Pravin U., Singh, Rishi P., Koh, Adrian, Ogura, Yuichiro, Weissgerber, Georges, Gedif, Kinfemichael, Jaffe, Glenn J., Tadayoni, Ramin, Schmidt-Erfurth, Ursula, Holz, Frank G. |
|---|---|
| Zdroj: | In Ophthalmology January 2021 128(1):89-99 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|